Health Trials

Role of Plasma Rich Growth Factor in Repair Primary Cleft Palate

ConditionsCleft PalatePlasma Rich in Growth Factors
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age6-18
SponsorCairo University

About this trial

Does the plasma-rich growth factor (PRGF) with primary cleft palate repair accelerate wound healing and prevent post-operative oronasal fistula occurrence?

Eligibility criteria

Qualifiers

systemically healthy patients (American Society of Anesthesiologists -ASA I and II); not older than 6-18 months

Patients with primary non-syndromic isolated cleft palate

Apprehensive to be in the study.

Disqualifiers

Patients with recurrent palatal fistula

Existence of syndromic cleft palate

Blood diseases and platelet disorders (hematological disease)

Systematic disease radiotherapy or chemotherapy for malignancy

Trial design

Treatments tested in this trial

  • Plasma Rich in Growth Factors (PRGF)
  • Placebo

Treatment groups

36 Participants
are divided into 2 treatment groups

Locations

1

Map coordinates are unavailable for these locations. Locations are shown below instead.

Faculty of Dentistry, Cairo University Status unavailable Manial, Cairo GovernorateEgyptEgypt

Sponsors and collaborators

Cairo University

Lead sponsor

Source ClinicalTrials.gov